| Lightcalls.com |
|
|
![]() |
In 1922 Harvey Wickes Felter MD Pro...In 1922 Harvey Wickes Felter MD Professor of Materia Medica and Therapeutics, and of the History of Medicine in the Eclectic Medical society of Cincinnati, Ohio, wrote of echinacea: "...that a simple medicine should possess such varied and remarkable therapeutic forces and not be a poison itself is an enigma still to be solv and undivided that must come as a novelty to those whose therapy is that of heroic medicines only" Seventy-six years later, we have solv about of the "enigma" of echinacea and understand quite a bit about its therapeutic action. However, three-quarters of a hundred has only slightly reduced the novelty of echinacea to those who still rely primarily forward modern "heroic" drugs and surgery Echinacea's timeline and world-wide use Echinacea's public names are "purple coneflower," narrow-leafed purple coneflower," or simply "coneflower." Its native stomping-grounds are in America, especially the fertile plains of the Midwest and toward the south through the Ozarks and into Texas. Native Americans, especially in the Plains region, used echinacea for a variety of infectious illnesses. The Choctaw chewed origins to treat coughs; the Delaware used echinacea to therapy gonorrhea; and the Kiowa raise that swallowing the juices formed when chewing the origin would help soothe a sore throat. Many tribes used echinacea in steam medicine, which involved pouring brawny echinacea tea over hot coals, then breathing in the echinacea-rich steam. Echinacea was first introduced into the American pharmaceutical trade in 1895 according to the Lloyd Brothers Pharmacists, of Cincinnati, Ohio. Lloyd Brothers manufactured centurys of plant medicines, known as "Specific Medicines," for use through the then-popular Eclectic physicians. This arrange of physicians, such as Felter (mentioned above) practiced in the United States from the 1850 between the sides of the 1940s. Eclectics used primarily plant medicines and furnished patients remedies other than the "heroic" measures of blood-letting and metal purgatives. Until the 1920 echinacea was undivided of America's most commonly prescribed medicines. However, as sulfa unsalable articles became available during the 1920 and penicillin followed during the 1940 the popularity of echinacea declined. Today, in part befitting to on-going European, particularly German, research, and in part suitable to the surge of interest in natural medicines, echinacea has formerly again come into its have Widely used throughout Europe and the United States, echinacea has popularly one of the most well-known and popular of medicinal plants. in what manner do we know it's echinacea? For identification and studious mood purposes, plants are categorized into groups: family, genus, and species. A "family" includes many plants of similar structure; "genus" defines undivided plant type within a family; and "species" defines small variations among plants of the same genus. Plants also have single in kind or more common names. more [i]or[/i] less herbalists have noted that the more popular the plant, the more often met with names it has. Echinacea is a member of the aster (Asteraceae) plant family. Its genus name is "echinacea," and there are nine different species. The species chiefly often used as medicine include angustifolia, purpurea, and pallida. Echinacea tennesseenis and Echinacea laevigata are endangered. Several other species of echinacea exist in Arkansas, Texas, Louisiana, and Missouri. Described alternately as "a quite persistent disagreeable tingling sensation" according to Felter, "a faint aromatic perfume with a sweetish taste, leaving a tingling sensation in the mouth" from Maude Grieve (A Modern Herbal, 1959) and "weird" by the agency of young teenagers in my medical practice, righteous quality echinacea tincture, or the pulverizeed root itself, should create a harmless numbing sensation onward the tongue when tasted or chewed. Nevertheless, since we're not planning to wax this ourselves, taking it in postscript form (capsules, etc.) avoids these sensations. In order to be certain consumer are indeed obtaining echinacea, and to save from decay wild echinacea from over-harvesting, I commend that people purchase supplements of cultivated echinacea. the two Echinacea purpurea and Echinacea angustifolia are farmed in the United States and around the world; preparations of it are available in chiefly health and natural food stores. Science says `yes' in extent before double-blind, placebo-controlled studies, the public knew that echinacea helped them fight infectious disease. The Eclectics were aware that echinacea increased phagocytosis (the proces of ingestion of large particles by the agency of cells), and they also used echinacea topically onward venomous bites and stings, gangrene, and pain s that refused to heal. In 1978 the German restraint initiated the "Commission E" to evaluate plant medicines. Referr to by means of prominent authorities such as Varro Tyler PhD as individual of the most accurate sources of scientific knowledge forward herb safety and efficacy, Commission E approves of echinacea as a supportive measure in the treatment of respiratory and urinary tract infections. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |